Turkey’s COVID19 vaccine makes emergency use authorization application: Health Minister

COVID-19 vaccine Turkovac started on phase III trials with 40,800 participants in June.

Ekleme: 25.11.2021 13:41:07 / Güncelleme: 25.11.2021 13:41:07 / English News / Ankara Haberleri
Destek için 

“The emergency authorization application for Turkovac has been submitted to the Turkish Medicines and Medical Devices Agency (TITCK),” the country’s Health Minister Fahrettin Koca said while speaking in the capital Ankara during the Planning and Budget Commission meeting at Parliament.

TURKOVAC, which was temporarily named as ERUCOV-VAC, is a COVID-19 vaccine candidate developed by the Health Institutes of Turkey and Erciyes University. (ILKHA)